Enalaprilat (Teva Parenteral Medicines, Inc.)


Welcome to the PulseAid listing for the Enalaprilat drug offered from Teva Parenteral Medicines, Inc.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Parenteral Medicines, Inc.
NON-PROPRIETARY NAME: Enalaprilat
SUBSTANCE NAME: ENALAPRILAT
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2005-10-06
END MARKETING DATE: 0000-00-00


Enalaprilat HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEnalaprilat from Teva Parenteral Medicines, Inc.
LABELER NAME: Teva Parenteral Medicines, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1.25(mg/mL)
START MARKETING DATE: 2005-10-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0703-8401_d3b2d6be-40c0-4e47-a762-9289fee37617
PRODUCT NDC: 0703-8401
APPLICATION NUMBER: ANDA075578

Other ENALAPRILAT Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthEnalaprilat
Hospira, Inc.ENALAPRILAT
Teva Parenteral Medicines, Inc.Enalaprilat
West-ward Pharmaceutical CorpEnalaprilat